Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

CLABSI - Central Line Associated Bloodstream Infection Catheter-Related Blood Stream Infection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Cologne

Cologne, 50937, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

every patient in the hemato-oncological department who received at least one CVC was included in the study

Exclusion criteria

none

Treatment and study plan

70% isopropyl alcohol-impregnated catheter caps

Device

Implementation of 70% isopropyl alcohol-impregnated catheter caps in order to assess the number of CLABSI diagnosed during 1 Year

Other names: CUROS (3M), self disinfecting catheter caps

Primary outcomes

Number of CLABSI

Time frame: 12 Months

To assess the clinical efficacy of Curos in preventing CLABSI in a high-risk department (oncology and ICU)

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Registry information

Acronym: STERILE

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2020
First posted: Sep 1, 2020
Registry last updated: Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed